Key Topics from BTOG 2025 | Lung Cancer Nursing UK

Key Topics from BTOG 2025

Tuesday 18th March, 18:30 - 19:30

Our third webinar of the year features Dr Shobhit Baijal to share with us an update from the 23rd BTOG (British Thoracic Oncology Group) Annual Conference 2025 held in Belfast. If you are unable to attend the event in Belfast this year, this webinar will ensure you do not miss out on the important updates being shared.

Dr Baijal will highlight and discuss:

  • the key topics shared
  • the learning aspects and takeaways from the event
  • the feedback received

All healthcare professionals are welcome to join this webinar and to participate in the Q&A session that will follow the presentation.

This webinar programme has been instigated by Lung Cancer Nursing UK. Sponsorship has been received by AstraZeneca UK Ltd to support the costs of this webinar series.  AstraZeneca has had no input into the development of topics, selection of speakers or the content of the webinars

If you wish to learn more about AstraZeneca’s lung cancer brands please reach out to your local AstraZeneca Oncology Account Manager.

Speakers

  • Shobhit Baijal

    University Hospital Birmingham NHS Trust
    Dr Shobhit Baijal is a Consultant Medical Oncologist based at The University Hospitals Birmingham NHS Trust and an Honorary Associate Professor at The University of Birmingham. He obtained a BSc Honours in immunology and cell pathology from University College London, before graduating with a medical degree from St Bartholomew’s Medical School in 2001. Dr Baijal returned to the Midlands to complete his general medical and oncology training and took up post as Consultant Medical Oncologist in September 2011.

    He actively treats lung and colorectal cancer patients at the Heartlands, Good Hope and Solihull sites. He specialises in all forms of cancer drug treatment including chemotherapy, immuno-oncology, precision oncology and chemo-embolisation.

    Dr Baijal has a large Clinical Trial portfolio and is the UK Chief and Principle Investigator for National and International studies.. He is an invited Medical Expert for NICE committee reviews for new anti-cancer drug therapies.

    As a Steering Committee member of the British Thoracic Oncology Group he has a pivotal role in supporting and educating Thoracic Oncology professionals across the United Kingdom. He is a Honorary Clinical Advisor for EGFR positive UK, on the Expert Panel for Roy Castle Foundation and is also an advisor to ALK Positive UK.